Related Experiment Video
Updated: Jun 9, 2026

Anti-Nuclear Antibody Screening Using HEp-2 Cells
Published on: June 23, 2014
Anti-Ku Antibodies in a Patient With a Polymyositis-Systemic Sclerosis Overlap Syndrome in Association With
Muhammad Zubair1, Maha Wazir2, Farhan Ullah3
1Rheumatology, Worthing Hospital, University Hospital Sussex NHS Foundation Trust, Worthing, GBR.
Abstract:
Overlap syndromes are well-described but rare clinical entities characterized by the co-presence of two or more connective tissue diseases. The combination of systemic sclerosis and polymyositis overlapping with autoimmune hepatitis (AIH) is particularly rare, as discussed in this case report. A 76-year-old woman with a recent history of pleuro-pericarditis presented with painful Raynaud's phenomenon, lethargy, jaundice, myalgias, and weight loss. Blood tests revealed a positive antinuclear antibody and anti-Ku antibody and raised creatine kinase, together with evidence of myositis and interstitial lung disease on imaging, leading to a diagnosis of polymyositis-systemic sclerosis overlap syndrome. Raised liver transaminases, immunological tests, and liver biopsy were consistent with AIH. She was managed with corticosteroids and mycophenolate mofetil. This is only the second instance in which AIH has been reported in the context of a positive anti-Ku antibody. We discussed the complex and rare nature of this condition and the various aspects of its management.
Related Concept Videos
Gastritis-II: Pathophysiology
In acute gastritis, the gastric mucosa becomes swollen and red and undergoes superficial erosion. Superficial ulceration may lead to bleeding.
In chronic gastritis, persistent or repeated insults lead to chronic inflammatory changes and, eventually, thinning or atrophy of the gastric tissue.
Gastritis can stem from various causes, each...
Myasthenia Gravis: Overview and Treatment
These antibodies interfere with the function of the nicotinic receptors in three ways: by binding to the receptor and disrupting acetylcholine binding; by causing cross-linking of receptors which leads...
Myasthenia Gravis ll: Pathophysiology
